NDATOPICALLOTION
Approved
Dec 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 15h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KLARON is a topical lotion formulation of sodium sulfacetamide, a sulfonamide antibiotic approved in 1996 for treatment of bacterial skin infections and acne-related conditions. The drug works by inhibiting bacterial folate synthesis, reducing pathogenic flora on the skin. It is applied directly to affected areas and has been a mainstay therapy in dermatology for nearly three decades.
LOE Approaching
As a mature product nearing loss of exclusivity, the KLARON brand team is likely consolidated and focused on managed care pricing and retention rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on KLARON offers limited growth trajectory as a mature, patent-expiring product; career value lies in managed care negotiation and retention strategy rather than innovative launch experience. Professionals seeking high-visibility, growth-stage roles should consider this a consolidation or legacy brand opportunity.
Brand ManagerRegional Sales Manager
Worked on KLARON at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.